A polymerase chain reaction (PCR)-based detection system was established to identify the presence of bovine leukosis virus (BLV) DNA in bovine semen. Seventy-nine bulls were included in the study. Serum, peripheral blood leukocytes, and semen were collected from each of the 79 bulls. The BLV-specific antibody was detected in serum by agar gel immunodiffusion and viral DNA in blood and semen by PCR. Serologically, 29 of the 79 bulls were BLV positive. Twenty-seven of the 29 seropositive bulls and 1 of the seronegative bulls had BLV DNA in peripheral blood leukocytes. All 79 bulls tested PCR negative for the presence of BLV in semen. This data is strong evidence that properly collected semen from BLV seropositive bulls will not contribute to dissemination of this viral infection.
Bovine leukosis virus (BLV)
is an exogenous oncogenic retrovirus associated with enzootic bovine leukosis. The infection can result in 3 different clinical states, with many animals remaining asymptomatic in an aleukemic state (AL). However, 30-70% develop a persistent lymphocytosis (PL) characterized by a polyclonal expansion of B-lymphocytes and a much smaller percent, 0.1-10%, eventually develop lymphoid tumors. 3, 6, 11, 12 A previous survey published in 1985 suggested up to 30% of dairy cows in the United States were infected with BLV. 12 Due to the relatively short life of production cattle in the United States, the greatest economic impact of BLV infection would appear to be that associated with interference in the international movement of cattle and their germ plasm rather than clinical disease. Thus, application of molecular biology techniques, such as polymerase chain reaction (PCR), to identify the presence of BLV in semen should facilitate certification of germ plasm as being free of contaminating virus.
Previous studies by numerous investigators suggested that semen from BLV-infected bulls was noninfectious for recipient cows. 4, 8, 9 Sheep inoculated with entire ejaculates from BLV-infected bulls remained seronegative. Cows inseminated with ejaculates from seropositive bulls have also not seroconverted nor have their progeny. In addition, a 5-year study demonstrated that use of semen derived from both BLV seropositive and seronegative donor bulls in a BLV-free closed dairy did not result in any seroconversion. Donor bulls were from multiple artificial insemination (AI) centers, with 48% being seropositive. 9 Despite the above-mentioned studies that argued strongly against the possibility of recipient cows becoming infected by using semen from BLV-positive bulls, international movement of germ plasm from BLV-infected animals is still problematic. The most common method of testing for BLV in animals is the detection of antibodies to gp51 by agar gel immunodiffusion (AGID). However, the application of PCR for identification of viral DNA has provided a sensitive test for detecting BLV in tissues such as blood. 1, 2, 10 This report describes the application of PCR to the detection of BLV DNA in peripheral blood leukocytes and semen of bulls. Such analysis should facilitate the international movement of germ plasm derived from seropositive animals.
Materials and methods
Animals. Seventy-nine bulls were used to collect serum, peripheral blood leukocytes, and semen, the latter being collected by standard AI industry procedures. a Serology. Serum samples from each bull were tested by AGID for the presence of BLV gp51 antibody using a commercially available kit. b DNA extraction. DNA from peripheral blood leukocytes (buffy coat) was extracted using a commercial kit according to the manufacturer's instructions. c Extended semen samples were removed from the straws, with half being treated by centrifugation to concentrate the sperm and any associated cells and cellular debris. DNA from extended and concentrated semen was extracted using a previously described Chelax technique. 14 Briefly, 3 l of semen samples were added to 200 l of 5% Chelax d solution in 1.5-ml Eppendorf tubes. Two microliters Proteinase K e and 7 l DTT (dithiothreitol) e were added and tubes incubated at 56 C for 1 hr. Samples were vortexed for 10 sec, centrifuged at 14 ϫ g for 20 sec, placed in a boiling water bath for 8 min, vortexed 10 sec, and centrifuged for 3 min at 14 ϫ g.
Select semen samples were spiked with BLV-infected fetal lamb kidney (FLK) cells 13 to identify the presence of any semen-associated inhibiting factors that might interfere with the extraction of DNA and/or PCR reaction. Ten-fold dilu- Table 1 . Identification of BLV gp51-specific antibody (AGID) and BLV tax sequence (PCR) in peripheral blood of bulls.
Number of bulls tested
Serology PCR 27 2* 1 49
* These 2 animals were tested on 3 separate dates over a 1-year period.
tions of BLV-FLK cells, ranging from 100 cells up to 10 7 cells, were added to a straw of semen prior to DNA extraction. The relative sensitivity of the PCR was established by spiking lymphocytes derived from the peripheral blood of seronegative control cattle with BLV-FLK cells. Lymphocytes from noninfected cattle were spiked in ratios ranging from 1:1 (infected FLK-BLV vs. noninfected lymphocyte) to 1:10 7 .
Polymerase chain reaction. Five microliters of peripheral blood leukocyte-derived DNA and 30 l of semen DNA from extended and concentrated semen were used for each PCR reaction. Primers to the tax region of BLV were used for amplification. Primer sequences were upstream, 5Ј-GGGA-AGCTTCGATACCCTCCTTGTGGACC-3Ј; downstream, 3Ј-CCAGGCTTAACCAACGATCGTCCAGGGGG-5Ј. The reagent concentrations for PCR were as follows: 10ϫ buffer f at 1.25ϫ, MgCl 2 f (25 mM) at 2.5 mM, deoxynucleotide (d-NTPs) f (10 mM) at 200 M, primers g (20 M; tax) at 0.2 M, Taq polymerase f at 2.5 units/100 l reaction, UNG f (Uracil N-glycosylase) at 1 unit/100 l reaction, and 2ϫ filtered sterile ddH 2 O. All samples were subjected to PCR using bovine ␤-actin specific primers to insure DNA quality.
All samples were assayed using a wax barrier in a hotstart technique f according to instructions. This technique permits the separation of dNTPs and primers from the template and polymerase, hence preventing formation of primer-dimers and nonspecific DNA repair by Taq polymerase. The primers, dNTPs, and MgCl 2 were placed in the reaction tube followed by the addition of wax; tubes were then heated to 80 C for 5 min to melt the wax and quickly cooled to 25 C for 1 min to form a plug to prevent the lower and upper reagents from mixing. Tubes containing the lower reagent were held at 4 C until ready to use.
The parameters for the PCR reaction were as follows: 95 C for 1 min; 95 C for 45 sec, 60 C for 30 sec, 72 C for 1.5 min for 35 cycles; 72 C for 10 min; soak at 4 C.
Southern blot analysis. PCR products were electrophoresed in 2% agarose gels in 1ϫ TAE buffer (0.04 M Trisacetate, 0.001 M EDTA, pH 8.3) at 80 V for 4 hr. Ten microliters of DNA and 1 l sample application buffer (0.25% bromophenol blue, 40% w/v sucrose in dH 2 O) were loaded per well. Following electrophoresis, DNA was transferred onto nylon membrane h using the VacuGene i according to the manufacturer's directions. The membrane was probed overnight with BLV probe to the tax region using nucleic acid hybridization and an enhanced chemiluminescence (ECL) detection system h according to the manufacturer's instructions.
Results
Serology (AGID) and PCR (using DNA from peripheral blood and semen) were conducted on all 79 animals ( Table 1) . Twenty-seven of 29 seropositive bulls were BLV positive by PCR in the blood. The other 2 seropositive animals were PCR negative in the blood. These latter 2 bulls were bled an additional 3 times during the next 12 months for PCR analysis; both remained negative. One of the 50 seronegative bulls was PCR positive for BLV in peripheral blood; follow-up samples on this animal could not be obtained. All semen DNA samples, regardless of serology, proved to be negative by PCR.
All DNA samples, whether from peripheral blood or semen, were tested for the presence of ␤-actin encoding DNA by PCR; all samples were positive, confirming the presence of DNA (data not shown). Select semen samples were spiked with BLV-infected FLK cells to identify the presence of any semen-associated inhibiting factors that might interfere with the BLV-PCR reaction. A minimum of 10 5 FLK-BLV cells had to be added to a straw of semen prior to DNA extraction for the PCR to be positive. A similar titration of BLV-FLK cells into negative control peripheral blood mononuclear leukocytes resulted in a sensitivity of detection of 1 infected cell in 10 6 noninfected leukocytes (Fig. 1 ).
Discussion
Bovine leukosis virus has compromised domestic and international movement of semen from seropositive bull studs. International exportation of semen typically requires that the entire stud, not the individual animal, be BLV seronegative for several months before and after the semen collection dates. Maintaining this standard is time-consuming and economically costly. The development of sensitive assay(s) to directly test semen for the presence of virus should facilitate the use of seropositive bulls as semen donors for domestic and international distribution.
This study was conducted to establish the use of PCR amplification in detecting BLV in semen. All bulls in the study were serologically tested for the presence of BLV-specific antibody using AGID, the most accepted test in establishing the presence of BLV antibody and infection. The PCR for BLV was performed on DNA extracted from buffy coats of all animals. Twenty-seven of the 29 seropositive bulls were PCR positive for BLV. The 2 seropositive bulls were retested an additional 3 times and remained PCR negative. In reality, a seropositive result should not necessarily imply clinical disease, active shedding of virus, or even that the animal is infected. While serology merely tests for the presence of antibodies, PCR is used to amplify a portion of viral DNA, allowing detection of trace amounts of virus contamination. The seropositive bulls remaining PCR negative may be due to 2 possibilities: 1) the animals were infected and seroconverted but the virus remained sequestered somewhere other than in the peripheral blood, or 2) these 2 bulls were able to eliminate the viral infection, which should not be considered out of reason.
On the opposite spectrum, all but 1 seronegative bull was PCR negative. This may be due to the sensitivity limitations of AGID or recent infection. Due to the sensitivity of PCR, the presence of virus can be detected before seroconversion, hence detecting false seronegatives. The BLV DNA was detected by PCR in the peripheral blood of calves 17-18 days after experimental infection, while seroconversion required 28-50 days postinfection. 5 Relative to identification of BLV in semen, a minimum of 2 straws from each bull was analyzed. In addition to using BLV tax-specific primers in the semen PCR, BLV pol-and gag-specific primers were also employed in separate reactions (data not shown). Bovine leukosis virus contamination was not detectable by PCR in DNA extracted from any semen despite the presence of infected cells in blood samples. The BLV-infected FLK cells were used to spike con-centrated semen prior to the extraction of DNA. This was done to determine if BLV-infected cells can be detected in semen and thus validate the PCR. Because we did not attempt to count the number of cells present in semen, a dilution ratio of FLK-BLV cells to sperm number could not be determined. However, at least 10 5 FLK-BLV cells were needed in 200 l of extended semen to be detected by PCR. The FLK-BLV cells were also used to spike mononuclear leukocytes from noninfected animals to better determine the PCR sensitivity. The addition of infected cells to noninfected leukocytes was conducted in 2 ways: 1) FLK-BLV cells were added to normal lymphocytes in ratios of 1:1 to 1:10 7 before DNA extraction, and 2) DNA was extracted individually from FLK-BLV cells and normal lymphocytes, then mixed at a ratio of 1:1 infected cells to 1:10 7 noninfected leukocytes. Dilution ratios as low as 1 BLV-infected FLK cell in 10 6 noninfected cells was detectable by PCR. These results would be supported by previous studies directed at defining PCR sensitivity for detecting BLV provirus in the peripheral blood of infected animals; limits of detection were at 1 pg of viral DNA, 10 less than 8 proviral copies (2-3 BLV-infected FLK cells) in 2 ϫ 10 6 negative lymphocytes, 1 and 1 BLV-positive cell in 2,000 noninfected cells in experimentally infected calves. 5 These latter studies would support the use of PCR for diagnostic purposes.
A previous report has described BLV in bovine semen collected by massage of the pelvic genitalia. 7 However, this positive finding may not have been due to natural BLV shedding in semen but rather blood contamination due to collection technique or inflammatory disease. Poor collection technique 4 resulting in tissue trauma and associated inflammation can cause leukocyte infiltration, and in the case of a BLV-infected bull, would result in a PCR positive in a semen collection. In summary, the combined use of proper AI collection techniques, microscopic evaluation of semen for contaminating leukocytes, and application of a BLV-specific PCR to representative straws of semen from each ejaculate should provide sufficient confirmation of a BLV-free status, even when employing seropositive bulls as donors.
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